There may be a shift from TIGIT–CD226+ CD4 cells to TIGIT+CD226+ CD4 cells under chronic stimulation, i.e., an altered balance between different TIGIT/CD226 phenotype subsets in patients with DM. This evidence concerns the gene CD4 and dermatomyositis.